Oncology Resource Center
Click on the subcategory below to find drug monographs for that particular area.
- Bladder, kidney, and other urologic cancers
- Bone and connective tissue cancer
- Breast cancer
- CNS cancer
- Colorectal and other GI cancers
- Cytoprotective and supportive care agents
- Eye cancer
- Gynecologic cancer
- Head and neck cancer
- Kaposi's sarcoma
- Leukemias, lymphomas, and other hematologic cancers
- Melanoma and other skin cancers
- Pancreatic, thyroid, and other endocrine cancers
- Prostate and other male cancers
- Respiratory and thoracic cancers
Teva announced a voluntary recall of 6 lots of Adrucil (fluorouracil injection) 5g/100mL (50mg/mL) due to potential particulate matter identified as aggregate of silicone rubber pieces from a filler diaphragm and fluorouracil crystals.
The FDA has approved Kyprolis (carfilzomib; Amgen) in combination with lenalidomide and dexamethasone for the treatment of patients with relapsed multiple myeloma who have received 1-3 prior lines of therapy.
Novartis announced that the Food and Drug Administration (FDA) has approved Odomzo (sonidegib) capsules for the treatment of adults with locally advanced basal cell carcinoma (laBCC) that has recurred following surgery or radiation therapy, or those who are not candidates for surgery or radiation therapy.
Researchers found benefit from aromatase inhibitors and bisphosphonates
But whether this could trigger cancer or other health issues remains unclear
Make prescribing decisions with our comparative charts and treatment algorithms.
Quickly and accurately perform clinical calculations.
Featured courses from myCME
Radiation oncologists and residents will appreciate the experience of the renowned faculty of the Comprehensive ...
This activity is designed to change health provider attitudes on chronic pain and willingness to ...
Among the many issues clinicians face today, staying current with advances in medicine is becoming ...